Vitrolife Management

Management criteria checks 2/4

Vitrolife's CEO is Bronwyn Brophy O´Connor, appointed in Aug 2023, has a tenure of less than a year. total yearly compensation is SEK7.44M, comprised of 74.5% salary and 25.5% bonuses, including company stock and options. directly owns 0.014% of the company’s shares, worth SEK3.14M. The average tenure of the management team and the board of directors is 1 years and 6.3 years respectively.

Key information

Bronwyn Brophy O´Connor

Chief executive officer

kr7.4m

Total compensation

CEO salary percentage74.5%
CEO tenureless than a year
CEO ownership0.01%
Management average tenureless than a year
Board average tenure6.3yrs

Recent management updates

Recent updates

Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt

Apr 03
Vitrolife (STO:VITR) Is Carrying A Fair Bit Of Debt

A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Mar 07
A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now

Feb 05
Vitrolife AB (publ) Just Missed Earnings; Here's What Analysts Are Forecasting Now

Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion

Jan 05
Vitrolife AB (publ)'s (STO:VITR) Share Price Matching Investor Opinion

Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching

Dec 15
Here's Why We Think Vitrolife (STO:VITR) Is Well Worth Watching

Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Nov 27
Calculating The Intrinsic Value Of Vitrolife AB (publ) (STO:VITR)

Is Vitrolife (STO:VITR) A Risky Investment?

Nov 06
Is Vitrolife (STO:VITR) A Risky Investment?

An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued

Aug 25
An Intrinsic Calculation For Vitrolife AB (publ) (STO:VITR) Suggests It's 27% Undervalued

Vitrolife (STO:VITR) Could Easily Take On More Debt

Aug 03
Vitrolife (STO:VITR) Could Easily Take On More Debt

Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?

May 26
Are Vitrolife AB (publ) (STO:VITR) Investors Paying Above The Intrinsic Value?

Is Vitrolife (STO:VITR) A Risky Investment?

Jan 23
Is Vitrolife (STO:VITR) A Risky Investment?

Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly

Oct 18
Vitrolife (STO:VITR) Seems To Use Debt Quite Sensibly

Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Sep 09
Calculating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Is Vitrolife (STO:VITR) A Risky Investment?

Jul 07
Is Vitrolife (STO:VITR) A Risky Investment?

A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

May 26
A Look At The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Vitrolife (STO:VITR) Seems To Use Debt Rather Sparingly

Mar 31
Vitrolife (STO:VITR) Seems To Use Debt Rather Sparingly

Estimating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

Feb 07
Estimating The Fair Value Of Vitrolife AB (publ) (STO:VITR)

There May Be Reason For Hope In Vitrolife's (STO:VITR) Disappointing Earnings

Apr 29
There May Be Reason For Hope In Vitrolife's (STO:VITR) Disappointing Earnings

Is Vitrolife AB (publ)'s (STO:VITR) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Mar 16
Is Vitrolife AB (publ)'s (STO:VITR) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Who Has Been Selling Vitrolife AB (publ) (STO:VITR) Shares?

Jan 22
Who Has Been Selling Vitrolife AB (publ) (STO:VITR) Shares?

Vitrolife (STO:VITR) Shareholders Have Enjoyed An Impressive 289% Share Price Gain

Dec 18
Vitrolife (STO:VITR) Shareholders Have Enjoyed An Impressive 289% Share Price Gain

CEO Compensation Analysis

How has Bronwyn Brophy O´Connor's remuneration changed compared to Vitrolife's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

-kr4b

Dec 31 2023kr7mkr6m

-kr4b

Compensation vs Market: Bronwyn's total compensation ($USD682.94K) is about average for companies of similar size in the Swedish market ($USD795.88K).

Compensation vs Earnings: Insufficient data to compare Bronwyn's compensation with company performance.


CEO

Bronwyn Brophy O´Connor (49 yo)

less than a year

Tenure

kr7,439,000

Compensation

Ms. Bronwyn Brophy O´Connor is President and Chief Executive Officer at Vitrolife AB (publ) since joining from August 01, 2023. She has an impressive track record as a leader of global Life science and Med...


Leadership Team

NamePositionTenureCompensationOwnership
Bronwyn Brophy O´Connor
CEO & Presidentless than a yearkr7.44m0.014%
SEK 3.1m
Patrik Tolf
Chief Financial Officer2.3yrsno data0.0096%
SEK 2.1m
Claus Bisgaard
Senior Vice President of Technologiesno datano data0.00028%
SEK 61.5k
Guillermo Ferrando
Vice President Strategy & Corporate development1.3yrsno datano data
Olivia Natens
Senior Vice President of Sales & Marketingless than a yearno datano data
Frank Pettersson
Acting Senior Vice President of HR & Sustainabilityno datano data0.0013%
SEK 287.5k
Rickard Ericsson
Senior Vice President of Consumablesless than a yearno data0.0061%
SEK 1.3m
Ricardo Capella
Senior Vice President Genetic Services2.3yrsno data0.0044%
SEK 972.3k

1.0yrs

Average Tenure

52.5yo

Average Age

Experienced Management: VITR's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Henrik Blomquist
Director4.9yrskr883.00kno data
Jon Sigurdsson
Chairman of the Board9.3yrskr1.25m0.022%
SEK 4.9m
Lars Holmqvist
Independent Director6.3yrskr450.00kno data
Pia Marions
Independent Director11yrskr500.00k0.0037%
SEK 809.9k
Karen Soerensen
Independent Director3.8yrskr500.00kno data

6.3yrs

Average Tenure

61yo

Average Age

Experienced Board: VITR's board of directors are considered experienced (6.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.